Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrellus Health. Regulatory News (TRLS)

Share Price Information for Trellus Health. (TRLS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.05 (-3.13%)
Spread: 0.10 (6.667%)
Open: 1.60
High: 1.60
Low: 1.55
Prev. Close: 1.60
TRLS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

26 Jun 2024 07:00

RNS Number : 8622T
Trellus Health PLC
26 June 2024
 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Trellus Health plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Mr Ian Amiee

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.) v

Name

Ian Amiee, Daryl Amiee, Doolittle act Amiee SSAS

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

25/06/2024

6. Date on which issuer notified (DD/MM/YYYY):

25/06/2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

3.32%

3.32%

5,365,000

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Ordinary sharesGB00BNNFM402

5,365,000

3.32%

SUBTOTAL 8. A

5,365,000

3.32%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

London

Date of completion

25/06/2024

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAPKSAANLEFA
12
Date   Source Headline
26th Jun 20247:00 amRNSHolding(s) in Company
24th Jun 20245:15 pmRNSHolding(s) in Company
19th Jun 20243:53 pmRNSHolding(s) in Company
14th Jun 20245:19 pmRNSHolding(s) in Company
14th Jun 20241:23 pmRNSResult of AGM
7th Jun 20247:00 amRNSDirectorate Changes
20th May 20245:16 pmRNSPosting of Annual Report & Accounts & AGM Notice
30th Apr 202411:29 amRNSHolding(s) in Company
23rd Apr 20247:00 amRNSPreliminary Results
17th Apr 20244:16 pmRNSHolding(s) in Company
16th Apr 20245:02 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSNotice of Results
2nd Apr 20244:36 pmRNSHolding(s) in Company
5th Mar 20247:00 amRNSGrant of Share Options
28th Feb 202412:00 pmRNSDirectorate Change
28th Feb 20247:00 amRNSAgreement with US Health Plan
28th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSNotice of Results
12th Sep 20237:00 amRNSAppointment of Chief Financial Officer
22nd Jun 20231:37 pmRNSResult of AGM
13th Jun 20237:00 amRNSRelated Party Transactions
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
23rd May 20237:00 amRNSFinal Results
28th Apr 20237:00 amRNSNotice of Results
6th Mar 20237:00 amRNSTrading Update
17th Feb 20237:00 amRNSLaunch of D2C IBS Offering
13th Feb 20237:00 amRNSNew York Medicaid Health Plan Agreement
6th Feb 20237:01 amRNSDirectorate Change
20th Dec 20227:00 amRNSTrading Update & Related Party Transaction
14th Dec 20225:28 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSTrellus IBD program launches on GI OnDEMAND
17th Oct 20227:00 amRNSTwo contracts signed with Mount Sinai
5th Oct 20229:06 amRNSSecond Price Monitoring Extn
5th Oct 20229:00 amRNSPrice Monitoring Extension
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn
30th Sep 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
26th Sep 20227:00 amRNSMarla Dubinsky a recipient of 2022 Sherman Prize
22nd Sep 20227:00 amRNSNotice of Results and Investor Presentation
1st Aug 20227:00 amRNSAppointment of Chief Financial Officer
19th Jul 20227:00 amRNSDirectorate Changes
27th Jun 20222:47 pmRNSResult of AGM and voting results
23rd Jun 20227:00 amRNSDirectorate Change
25th May 202212:00 pmRNSPosting of Annual Report & Accounts
10th May 20227:01 amRNSInvestor Presentation
10th May 20227:00 amRNSFinal Results
7th Apr 20227:00 amRNSNotice of Results
28th Feb 20227:00 amRNSDirect to Consumer market launch in New York
21st Jan 20227:00 amRNSAppointment of Chief Financial Officer
17th Jan 20227:00 amRNSClinical research update on GRITT(tm) methodology
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.